Breast cancer drug now treats men

Formulary Watch reports that the FDA has expanded the indication for the Pfizer drug palbociclib to treat breast cancer in male patients. Janet Serluco, VP, Access Experience Team, Oncology Lead at Precision Medicine Group, comments on the implications for patients and for Pfizer.

Read the article

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.